Human Immunodeficiency Virus–Associated Pulmonary Arterial Hypertension Diagnosed Postpartum

2015 ◽  
Vol 125 (1) ◽  
pp. 193-195 ◽  
Author(s):  
Tondra Newman ◽  
John M. Cafardi ◽  
Carri R. Warshak
2013 ◽  
Vol 2013 ◽  
pp. 1-11 ◽  
Author(s):  
Aibek E. Mirrakhimov ◽  
Alaa M. Ali ◽  
Aram Barbaryan ◽  
Suartcha Prueksaritanond

Human immunodeficiency virus- (HIV-) related pulmonary arterial hypertension (PAH) is a rare complication of HIV infection. The pathophysiology of HIV-related PAH is complex, with viral proteins seeming to play the major role. However, other factors, such as coinfection with other microorganisms and HIV-related systemic inflammation, might also contribute. The clinical presentation of HIV-related PAH and diagnosis is similar to other forms of pulmonary hypertension. Both PAH-specific therapies and HAART are important in HIV-related PAH management. Future studies investigating the pathogenesis are needed to discover new therapeutic targets and treatments.


Sign in / Sign up

Export Citation Format

Share Document